Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation [5]

Bone Marrow Transplantation

Volumn 38, Issue 5, 2006, Pages 393-394

  Qazilbash, M H ^a   Ueno, N T ^a   Hosing, C ^a   De Lima, M ^a   Cortes, J ^a   Massaro, A ^a   Rivera, Z ^a   Deavers, M ^a   Adachi, J A ^a   Champlin, R E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIFUNGAL AGENT; CLADRIBINE; CORTICOSTEROID; CYTARABINE; IMATINIB; IVERMECTIN; METHOTREXATE; PEGINTERFERON; TACROLIMUS; TIABENDAZOLE;

ACUTE RESPIRATORY FAILURE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANAMNESIS; ARTIFICIAL VENTILATION; BLOATING; BONE MARROW BIOPSY; CASE REPORT; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL FEATURE; COLONOSCOPY; EOSINOPHIL COUNT; EPIGASTRIC PAIN; GRAFT VERSUS HOST REACTION; HUMAN; HYPEREOSINOPHILIC SYNDROME; LETTER; MALE; MULTIPLE ORGAN FAILURE; NAUSEA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECTUM BIOPSY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ANTHELMINTICS; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; HUMANS; HYPEREOSINOPHILIC SYNDROME; IVERMECTIN; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; STRONGYLOIDIASIS; THIABENDAZOLE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747378311     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705448     Document Type: Letter

References (10)

1. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1-27.
2. Bain BJ. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Hematol 2004; 77: 82-85.
3. Cortes J, Ault P, Koller C, Thomas D, Ferrajoli A, Wierda W et al. Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome. Blood 2003; 101: 4714-4716.
4. Ueno NT, Zhao S, Robertson LE, Consoli U, Andreeff M. 2-Chlorodeoxyadenosine therapy for idiopathic hypereosinophilic syndrome. Leukemia 1997; 11: 1386-1390.
5. Ueno NT, Anagnostopoulos A, Rondon G, Champlin RE, Mikhailova N, Pankratova OS et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 2002; 119: 131-134.
6. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17: 208-217.
7. Chitkara RK, Krishna G. Parasitic pulmonary eosinophilia. Semin Respir Crit Care Med 2006; 27: 171-184.
8. Siddiqui AA, Beru SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33: 1040-1047.
9. Marty FM, Lowry CH, Rodriguez M, Milner DA, Pieciak WS, Sinha A et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005; 41: E5-e8.
10. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000; 355: 43-44.